Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls

Journal of Interventional Cardiac Electrophysiology

Volumn 27, Issue 2, 2010, Pages 95-99

  Anselmi, Chiara Viviani ^a   Ferreri, Carla ^b   Novelli, Valeria ^a   Roncarati, Roberta ^a,c   Bronzini, Roberta ^a   Marchese, Giovanni ^a   Somalvico, Francesco ^a   Condorelli, Gianluigi ^a,c   Montenero, Annibale Sandro ^a   Puca, Annibale Alessandro ^a,c  

^a IRCCS MULTIMEDICA   (Italy)

^b Istituto per la Sintesi Organica e la Fotoreattività   (Italy)

^c CNR   (Italy)

Author keywords

Arrhythmias; Atrial fibrillation (AF); Atrial flutter (AFL); Fatty acid profile; Gas chromatography (GC)

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TRANS FATTY ACID;

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ERYTHROCYTE MEMBRANE; GAS CHROMATOGRAPHY; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; LIPID COMPOSITION; PRIORITY JOURNAL;

EID: 77954785776     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-009-9466-8     Document Type: Article

References (33)

1. Rosamond, W., Flegal, K., Furie, K., et al. (2008). Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117, e25-e146.
2. Fye, W. B. (2006). Tracing atrial fibrillation-100 years. New England Journal of Medicine, 355, 1412-1414.
3. Tsang, T. S., Miyasaka, Y., Barnes, M. E., et al. (2005). Epidemiological profile of atrial fibrillation: a contemporary perspective. Progress in Cardiovascular Diseases, 48, 1-8.
4. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., et al. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946-952.
5. Stewart, S., Hart, C. L., Hole, D. J., et al. (2002). A populationbased study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine, 113, 359-364.
6. Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., et al. (2004). Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 110, 1042-1046.
7. Go, A. S., Hylek, E. M., Phillips, K. A., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 285, 2370-2375.
8. Heeringa, J., van der Kuip, D. A., Hofman, A., et al. (2006). Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal, 27, 949-953.
9. Waldo, A. L. (2005). The interrelationship between atrial fibrillation and atrial flutter. Progress in Cardiovascular Diseases, 48, 41-56.
10. Waldo, A. L., &Feld, G. K. (2008). Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. Journal of the American College of Cardiology, 51, 779-786.
11. Bang, H. O., Dyerberg, J., &Hjoorne, N. (1976). The composition of food consumed by Greenland Eskimos. Acta Medica Scandinavica, 200, 69-73.
12. De Caterina, R., Madonna, R., Zucchi, R., et al. (2003). Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. American Heart Journal, 146, 420-430.
13. Kris-Etherton, P. M., Harris, W. S., &Appel, L. J. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747-2757.
14. Marchioli, R., Barzi, F., Bomba, E., et al. (2002). Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation, 105, 1897-1903.
15. Marchioli, R., Schweiger, C., Tavazzi, L., et al. (2001). Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lipids, 36 Suppl, S119-S126.
16. Weylandt, K. H., Kang, J. X., &Leaf, A. (1996). Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids. Lipids, 31, 977-982.
17. Brouwer, I. A., Heeringa, J., Geleijnse, J. M., et al. (2006). Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. American Heart Journal, 151, 857-862.
18. Frost, L., &Vestergaard, P. (2005). n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. American Journal of Clinical Nutrition, 81, 50-54.
19. Mozaffarian, D., Psaty, B. M., Rimm, E. B., et al. (2004). Fish intake and risk of incident atrial fibrillation. Circulation, 110, 368-373.
20. von Schacky, C. (2008). Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Current Opinion in Clinical Nutrition and Metabolic Care, 11, 94-99.
21. Reiffel, J. A., &McDonald, A. (2006). Antiarrhythmic effects of omega-3 fatty acids. American Journal of Cardiology, 98, 50i- 60i.
22. London, B., Albert, C., Anderson, M. E., et al. (2007). Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation, 116, e320-e335.
23. Harris, W. S. (2007). Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacological Research, 55, 217-223.
24. Harris, W. S., &Von Schacky, C. (2004). The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine, 39, 212-220.
25. Pepe, S., &McLennan, P. L. (2002). Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation, 105, 2303-2308.
26. Tanaka, T., Shen, J., Abecasis, G. R., et al. (2009). Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet, 5, e1000338.
27. Merrill, A. H., Jr., &Schroeder, J. J. (1993). Lipid modulation of cell function. Annual Review of Nutrition, 13, 539-559.
28. Ferreri, C., Kratzsch, S., Brede, O., et al. (2005). Trans lipid formation induced by thiols in human monocytic leukemia cells. Free Radical Biology and Medicine, 38, 1180-1187.
29. Bligh, E. G., &Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911-917.
30. Hodges, J. S., &Pihlstrom, B. L. (1998). Software support for clinical studies: review of nQuery Advisor release 2.0. Journal of Dental Research, 77, 525-526.
31. Fukuda, K., Davies, S. S., Nakajima, T., et al. (2005). Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circulation Research, 97, 1262-1269.
32. Vance, D. E., &Goldfine, H. (2002). Konrad Bloch-a pioneer in cholesterol and fatty acid biosynthesis. Biochemical and Biophysical Research Communications, 292, 1117-1127.
33. Puca, A. A., Andrew, P., Novelli, V., et al. (2008). Fatty acid profile of erythrocyte membranes as possible biomarker of longevity. Rejuvenation Res, 11, 63-72.